Cargando…

Potential role of lipoxin in the management of COVID-19: a narrative review

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection leads to the development of coronavirus disease 2019 (COVID-19), which causes endothelial dysfunction (ED), oxidative stress (OS), and inflammatory disorders. These changes cause hypoxia and cytokine storm with the development of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batiha, Gaber El-Saber, Al-Gareeb, Ali I., Elekhnawy, Engy, Al-kuraishy, Hayder M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483298/ https://www.ncbi.nlm.nih.gov/pubmed/36114383 http://dx.doi.org/10.1007/s10787-022-01070-3

Ejemplares similares

Nitazoxanide and COVID-19: A review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

COVID-19 and corticosteroids: a narrative review
por: El-Saber Batiha, Gaber, et al.
Publicado: (2022)

The possible role of ursolic acid in Covid-19: A real game changer
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

The crucial role of prolactin-lactogenic hormone in Covid-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

Cholinergic dysfunction in COVID-19: frantic search and hoping for the best
por: Nadwa, Eman Hassan, et al.
Publicado: (2022)

Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19
por: Al-kuraishy, Hayder M, et al.
Publicado: (2022)

The potential role of neopterin in Covid-19: a new perspective
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Traditional herbs against COVID-19: back to old weapons to combat the new pandemic
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy?
por: Alomair, Basil Mohammed, et al.
Publicado: (2022)

Potential role of tirzepatide towards Covid-19 infection in diabetic patients: a perspective approach
por: Batiha, Gaber El-Saber, et al.
Publicado: (2023)

COVID-19 and erythrocrine function: The roller coaster and danger
por: Al-kuraishy, Hayder M, et al.
Publicado: (2022)

Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

The effect of ramatroban on cytokine and thrombotic storms in Covid-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

Trimetazidine and COVID-19-induced acute cardiac injury: a missed key
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Hemolytic anemia in COVID-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

The potential link between Covid‐19 and multiple myeloma: A new saga
por: Al‐Kuraishy, Hayder M., et al.
Publicado: (2022)

Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Testosterone in COVID-19: An Adversary Bane or Comrade Boon
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Pathophysiology of Post-COVID syndromes: a new perspective
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

Niclosamide for Covid-19: bridging the gap
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19
por: Mostafa-Hedeab, Gomaa, et al.
Publicado: (2022)

Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
por: Babalghith, Ahmad O., et al.
Publicado: (2022)

The role of berberine in Covid-19: potential adjunct therapy
por: Babalghith, Ahmad O., et al.
Publicado: (2022)

Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Combination of Vitamin C and Curcumin Safeguards Against Methotrexate-Induced Acute Liver Injury in Mice by Synergistic Antioxidant Effects
por: Hasan Khudhair, Dhekra, et al.
Publicado: (2022)

Hippo-YAP signaling and SARS-CoV-2 infection: a new mechanistic pathway
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2023)

Response: Commentary: Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Deciphering the immunoboosting potential of macro and micronutrients in COVID support therapy
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

The potential molecular implications of adiponectin in the evolution of SARS-CoV-2: Inbuilt tendency
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

Covid-19 and development of heart failure: mystery and truth
por: Onohuean, Hope, et al.
Publicado: (2021)

The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
por: Alrouji, Mohammed, et al.
Publicado: (2023)

The potential role of scavenger receptor B type I (SR‐BI) in SARS‐CoV‐2 infection
por: Alkazmi, Luay, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n6k94jf2a4bk0mb9ns7n9pq6s9